We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
Technopath Clinical Diagnostics - An LGC Company

Download Mobile App




Events

ATTENTION: Due to the COVID-19 PANDEMIC, many events are being rescheduled for a later date, converted into virtual venues, or altogether cancelled. Please check with the event organizer or website prior to planning for any forthcoming event.

AACC and Life Diagnostics Partner to Relaunch AACC Middle East

By LabMedica International staff writers
Posted on 10 Feb 2022
Print article
Image: AACC Middle East (Photo courtesy of AACC)
Image: AACC Middle East (Photo courtesy of AACC)

The American Association for Clinical Chemistry (AACC Washington, D.C., USA) has announced a new collaboration with Life Diagnostics (Abu Dhabi, UAE) to relaunch AACC Middle East which will bring AACC's world-renowned education and scientific programs paired with a dynamic exhibit to Dubai, UAE, November 5-6, 2022.

AACC Middle East was first launched in 2018 as part of AACC's strategy to improve health outcomes globally, and it drew an overwhelmingly positive response during its initial two-year run. Like so many in-person events, it then went on hiatus after the emergence of COVID-19. However, as the pandemic has persisted and continued to challenge laboratory medicine professionals - the people on the frontlines of coronavirus testing worldwide - it has become more important than ever that AACC Middle East be resumed in order to provide lab professionals with the educational programming and networking opportunities they need at this crucial time.

AACC will work closely with Life Diagnostics in order to relaunch AACC Middle East for this purpose. The event's scientific program will feature experts from the US and the Middle East who will share gold standard, actionable information about the latest in clinical testing. Attendees will be able to come together safely and in-person with leaders in the field to share lessons learned from the pandemic to date. In addition, the exposition floor of AACC Middle East will feature the latest innovations in every area of clinical testing, including coronavirus testing, artificial intelligence (AI), mobile health, molecular diagnostics, mass spectrometry, next-generation sequencing (NGS), point of care (POC), and automation.

"We at AACC are very excited to partner with Life Dx and other content experts in the Middle East to bring this essential conference back to the region," said AACC President Dr. Stephen R. Master. "For the past two years, laboratory medicine professionals around the world have heroically risen to the challenges we've faced during the pandemic, and I hope this meeting will fuel attendees' innovation and create new research collaborations and connections with colleagues who understand what everyone in the field has been through over these past many months."

Related Links:
AACC 
Life Diagnostics 

Gold Supplier
SARS-CoV-2 Multiplex Real-Time RT-PCR Assay
GSD NovaPrime Plus SARS-CoV-2
New
Urine Analyzer
R-600S
New
Automated R-AST Solution
Radian BC
New
Automated Pathology Workstation
NanoMtrx 100 & 300

Print article

Channels

Clinical Chem.

view channel
Image: The analysis pipeline used to investigate associations between blood metabolites, later life brain imaging measures, and genetic risk for Alzheimer’s disease (Photo courtesy of University College London)

Lipid Measurements Show Potential as Alzheimer’s Disease Biomarkers

Brain changes accompanying ageing are varied and can include pathologies that lead to cognitive impairment, the commonest of which is Alzheimer’s disease (AD). Identifying blood-based signatures of brain... Read more

Molecular Diagnostics

view channel
Image: This image depicts a DNA molecule that is methylated on both strands on the center cytosine. DNA methylation plays an important role for epigenetic gene regulation in development and cancer (Photo courtesy of Wikimedia Commons)

Study Supports Use of Methylated DNA Biomarkers for Cancer Diagnosis and Prognosis

A recent study added weight to the theory that methylated DNA biomarkers could be used for cancer diagnosis and prognosis. Methylation is a biological process by which methyl groups are added to a DNA molecule.... Read more

Hematology

view channel
Image: Standard test for multiple myeloma provides clues of a rare, more deadly type (Photo courtesy of Pexels)

Standard Blood Cancer Test Provides Clues of Rare IgD Multiple Myeloma

IgD myeloma accounts for about 1% of common blood cancer multiple myeloma and has a worse prognosis. Specific testing for IgD myeloma is available at a handful of reference labs across the US, but takes... Read more
Copyright © 2000-2022 Globetech Media. All rights reserved.